Buy, Sell or Hold: Syneron Medical Ltd. (ELOS-Q) — Stock Predictions at Stockchase

skip to content

Home Daily Stock Opinions and Ratings Syneron Medical Ltd. (ELOS-Q)

0.00

0.00 (0.00%) 1d

WATCH

Have about $6 of cash per share. Earnings should be $1.60. Missed 2 quarters in a row and the stock took a hit. Some key people have left. Has created doubt, but the trend in the industry is very good. He sold his holdings. Would buy if they start growing again.

biotechnology / pharmaceutical

PAST TOP PICK

(A Top Pick Feb 15/06. Down 27%.) Disappointed two quarters in a row. Forward expectations by US analysts have dropped. Have sold some shares. The industry is doing well. He'll wait for one more quarter.

biotechnology / pharmaceutical

WATCH

Still likes it, but there are some worrisome things. Have lost some top level management. The earnings are growing, have a great balance sheet and lots of cash. Waiting to see what the next quarter brings. Trading around 10 X earnings which is not expensive.

biotechnology / pharmaceutical

PAST TOP PICK

(A Top Pick Feb 15/06. Up 6%.) The beauty treatment sector is doing very well. Still likes.

biotechnology / pharmaceutical

TOP PICK

Recently, the stock was hit pretty hard because of lower than expected earnings forecast. Thinks they will make $2/2.20 a share in ’06. They have $5 in cash per share. Not very expensive.

biotechnology / pharmaceutical

TOP PICK

Sells machines to health care clinics. Just got approval from the FDA for a cellulite product. Expects great demand. Earnings have been rising very rapidly. Low multiples.

biotechnology / pharmaceutical

PAST TOP PICK

(A Top Pick Feb3/05. Up 20%.) Still likes. Trying to get approval on a new product. Analysts forcast for next year is $1.60 but he believes it could be as high as $2.50/3.00.

biotechnology / pharmaceutical

TOP PICK

Health and cosmetic industry is growing very strong. Company is very innovative. In '04, their earnings grew about 100%. Have $3 cash per share. Will be launching a new product for sunlight. Trades at 25 X current earnings.

biotechnology / pharmaceutical

Showing 1 to 8 of 8 entries

«
‹
1
›
»

Syneron Medical Ltd.(ELOS-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Syneron Medical Ltd. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Syneron Medical Ltd.(ELOS-Q) Frequently Asked Questions

What is Syneron Medical Ltd. stock symbol?

Syneron Medical Ltd. is a OTC stock, trading under the symbol ELOS-Q on the (). It is usually referred to as or ELOS-Q

Is Syneron Medical Ltd. a buy or a sell?

In the last year, there was no coverage of Syneron Medical Ltd. published on Stockchase.

Is Syneron Medical Ltd. a good investment or a top pick?

Syneron Medical Ltd. was recommended as a Top Pick by on . Read the latest stock experts ratings for Syneron Medical Ltd..

Why is Syneron Medical Ltd. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Syneron Medical Ltd. worth watching?

In the last year 0 stock analysts on Stockchase covered Syneron Medical Ltd.. The stock is worth watching.

What is Syneron Medical Ltd. stock price?

On , Syneron Medical Ltd. (ELOS-Q) stock closed at a price of $.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

© Stockchase Inc.